Definition of the Mamu A*01 peptide binding specificity: Application to the identification of wild-type and optimized ligands from simian immunodeficiency virus regulatory proteins

Journal of Immunology

Volumn 165, Issue 11, 2000, Pages 6387-6399

  Sidney, J ^a   Dzuris, J L ^a   Newman, M J ^a   Johnson, R P ^a   Amitinder, K ^a   Walker, C M ^a   Appella, E ^a   Mothe, B ^a   Watkins, D I ^a   Sette, A ^a  

^a Epimmune   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; EPITOPE; LIGAND; PEPTIDE; REGULATOR PROTEIN; HLA ANTIGEN CLASS 1; IMMEDIATE EARLY PROTEIN; MAMU A 01 ANTIGEN; MAMU-A 01 ANTIGEN; OLIGOPEPTIDE; PEPTIDE FRAGMENT; VIRUS PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; BINDING AFFINITY; NONHUMAN; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; ALGORITHM; AMINO ACID SUBSTITUTION; ANIMAL; BINDING SITE; IMMUNOLOGY; MACACA; METABOLISM; PEPTIDE MAPPING; PROTEIN BINDING; PROTEIN ENGINEERING; SYNTHESIS;

ALGORITHMS; AMINO ACID SUBSTITUTION; AMINO ACIDS; ANIMALS; BINDING SITES; EPITOPES, T-LYMPHOCYTE; HISTOCOMPATIBILITY ANTIGENS CLASS I; IMMEDIATE-EARLY PROTEINS; LIGANDS; MACACA MULATTA; OLIGOPEPTIDES; PEPTIDE FRAGMENTS; PEPTIDE MAPPING; PROTEIN BINDING; PROTEIN ENGINEERING; SIMIAN IMMUNODEFICIENCY VIRUS; VIRAL REGULATORY PROTEINS;

EID: 0034353517     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.11.6387     Document Type: Article

References (56)

1. Cytotoxic T lymphocytes specific for the simian immunodeficiency virus
2. Co-evolution of human immunodeficiency virus and cytotoxic T-lymphocyte responses
3. T lymphocyte responses in HIV-1 infection: Implications for vaccine development
4. Characterization of the peptide binding motif of a rhesus MHC class I molecule (Mamu-A*01) that binds an immunodominant CTL epitope from simian immunodeficiency virus
5. Conserved MHC class I peptide binding motif between humans and rhesus macaques
6. Sequence motifs important for peptide binding to the human MHC class I molecule. HLA-A2
7. Prominent role of secondary anchor residues in peptide binding to HLA-A2.I molecules
8. Prominent roles of secondary anchor residues in peptide binding to HLA-A24 human class I molecules
9. Two distinct HLA-A*0101-specific submotifs illustrate alternative peptide binding modes
10. Definition of an HLA-A3-like supermotif demonstrates the overlapping peptide binding repertoires of common HLA molecules
11. Specificity and degeneracy in peptide binding to HLA-B7-like class I molecules
12. Two complementary methods for predicting peptides binding major histocompatibility complex molecules
13. Application of an artificial neural network to predict specific class I MHC binding peptide sequences
14. Amino-terminal alteration of the HLA-A*0201-restricted human immunodeficiency virus pol peptide increases complex stability and in vitro immunogenicity
15. Analogues of CTL epitopes with improved MHC class-I binding capacity elicit anti-melanoma CTL recognizing the wild-type epitope
16. Improved induction of melanoma-reactive CTL with peptides from the melanoma antigen gp100 modified at HLA-A*0201-binding peptides
17. Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma
18. Enhanced in vitro potency and in vivo immunogenicity of a CTL epitope from hepatitis C virus core protein following amino acid replacement at secondary HLA-A2.1 binding positions
19. Enhanced immunogenicity of HIV-1 vaccine construct by modification of the native peptide sequence
20. Functional differences between memory and naive CD8 T cells
21. Evidence that a single peptide-MHC complex on a target cell can elicit acytolytic T cell response
22. A comparison of regulatory features in primate lentiviruses
23. HIV's evasion of the cellular immune response
24. AIDS vaccine development in primate models
25. HIV-1 regulatory/accessory genes: Keys to unraveling viral and host cell biology
26. Regulation of HIV-1 transcription
27. HIV nef: The mother of all evil
28. Tackling tat
29. HIV-1: Fifteen proteins and an RNA
30. Tat trans-activator
31. The HIV-1 rev protein
32. Co-localization of HIV-1 Nef with the AP-2 adaptor protein complex correlates with Nef-induced CD4 down-regulation
33. Mechanism of Nef-induced CD4 endocytosis: Nef connects CD4 with the μ-chain of adaptor complexes
34. Grossly defective nef gene sequences in a human immunodeficiency virus type I-seropositive long-term nonprogressor
35. CD4 glycoprotein degradation induced by human immunodeficiency virus type I Vpu protein requires the function of proteasomes and the ubiquitin-conjugating pathway
36. Vif is crucial for human immunodeficiency virus type I proviral DNA synthesis in infected cells
37. + T lymphocytes
38. Human immunodeficiency virus type 1 Vif-mutant particles from restrictive cells: Role of Vif in correct particle assembly and infectivity
39. HIV-1 Vpr interacts with the nuclear transport pathway to promote macrophage infection
40. HIV-1, Vpr and the cell cycle
41. Tat-specific eytotoxic T lymphocytes select for SIV escape variants during resolution of primary viremia
42. Control of viral replication and disease onset in cynomolgus monkeys by HIV-1 TAT vaccine
43. The measurement of MHC/peptide interactions by gel infiltration
44. Several common HLA-DR types share largely overlapping peptide binding repertoires
45. The three-dimensional structure of peptide-MHC complexes
46. MHC ligands and peptide motifs: First listing
47. SSYFPEITHI: Database for MHC ligands and peptide motifs
48. Virus-specific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus Env and Nef
49. The role of HLA-A motifs in identification of potential CTL epitopes in human papillomavirus type 16 E6 and E7 proteins
50. Utilization of MHC class I transgenic mice for development of minigene DNA vaccines encoding multiple HLA restricted CTL epitopes
51. Identification of multiple simian immunodeficiency virus (SIV)-specific CTL epitopes in sooty mangabeys with natural and experimentally acquired SIV infection
52. The organization of human leucocyte antigen class I epitopes in HIV genome products: Implications for HIV evolution and vaccine design
53. + population
54. Three regions of HIV-1 gp160 contain clusters of immunodominant CTL epitopes